You are here

EMD Serono

Member Since 2012

Rehan J. Verjee

President of EMD Serono and Global Head of the Innovative Medicine Franchises for Merck KGaA

As President of EMD Serono and Global Head of the Innovative Medicine Franchises for Merck KGaA, Darmstadt, Germany, Rehan leads the North American biopharmaceutical business across the U.S. and Canada in addition to leading the global oncology and neurology & immunology specialty medicine franchises for the healthcare business of Merck KGaA, Darmstadt, Germany.

Prior to this role, Rehan served as Executive Vice President, Chief Marketing and Strategy Officer since October 2015, leading the global franchises of oncology, neurology & immunology, and infertility, in addition to global business development, market access, strategy and portfolio management, marketing operations and the medical device and services unit. Prior to this, he led the Canadian operations as Managing Director of EMD Serono Canada Inc.

Rehan holds a master’s degree in Molecular and Cellular Biochemistry from the University of Oxford in the U.K, and first joined the company in 2004.

CEO Cancer Gold Standard™

Gold Standard  Employer

Since 2011

Quote

Nearly all of us are impacted by cancer in some way. At EMD Serono we are committed to making a difference in the lives of patients, their loved ones and healthcare professionals, by accelerating innovation in oncology in order to develop therapies with the potential to transform the way cancer is treated. This commitment extends to our corporate family through employee wellness programs that are designed to help reduce the risk of cancer, promote early detection and provide quality care.

— Rehan J. Verjee

Gold Standard  Task Force Participation

Task Force Member(s): Ellen Spencer, Manager, Office of the President

Life Sciences Consortium

LSC  Task Force Participation

Task Force Member(s): Zhen Su, MD, MBA, Vice President of Medical Oncology

Project Data Sphere, LLC

an independent initiative of the Life Sciences Consortium

Data Provider

Data Provider to Project Data Sphere, LLC since 2015

Further Support

Founding Member, CEO Roundtable on Cancer - China

EMD Serono

We are the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. We focus exclusively on specialty care - integrating cutting-edge science with industry-leading patient support.

At EMD Serono, we recognized the potential of specialty pharmaceuticals and patient care long ago, and have been dedicated to delivering on their promise ever since.

We have a legacy of both trying to find solutions to hard to treat conditions, as well as developing patient assistance programs that help ensure that those who need our therapies are able to access them.

As one of the top five U.S. companies exclusively focused on specialty care, we see our innovation as a matter of balancing science with emotion – integrating our top minds in research and development with the insights from patients and health care practitioners confronting real- world concerns.